Short Chain Fatty Acid Metabolism in COPD
Completed · Not applicable
Conditions studied: Chronic Obstructive Pulmonary Disease
In brief
The short chain fatty acid (SCFA) metabolism has not been studied in subjects suffering from COPD. The purpose of this study is to compare the SCFA metabolism in COPD patients to healthy matched controls. This protocol is an extension of recent studies about protein digestion and absorption abnormalities in COPD patients. The investigators hypothesize that SCFA production might be lower in COPD patients than in healthy subjects.
Key facts
- Study ID
- NCT03327181
- Run by
- Texas A&M University
- People needed
- 63
- Starts
- 2017-04-19
- Expected to finish
- 2019-02-14
- Last updated by the study team
- 2025-09-30
Who can join
Age: 45 and older, up to 100. Sex: any. Healthy volunteers: accepted.
Where it is running
- Texas A&M University — College Station, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.